GlassScriptPhysician profile
Russell Broming
NPI 1154941425
$7,016.90
in general payments reported to CMS, 2019-2025
11 companies · $1,613 in 2025
The $1,613 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $672 · 2022: $1,140 · 2023: $1,533 · 2024: $2,059 · 2025: $1,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,189 · Education: $15.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,189.22 |
| Education | $15.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,634.32 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $1,706.85 | 2021-2025 | Versacross Access Solution, Rhythmia Mapping System, Farapulse |
| Abbott Laboratories | $1,220.06 | 2021-2024 | Amplatzer Amulet, Ensite Precision, Viewmate |
| Cordis US Corp. | $108.64 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Cardiva Medical, INC. | $103.26 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $56.96 | 2021-2022 | |
| Pfizer INC. | $53.12 | 2022-2025 | |
| Biosense Webster, INC. | $48.90 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $40.48 | 2023 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $29.72 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Broming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.